ACS Medicinal Chemistry Letters · 2013 · 49 citations · 21 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryStructure-activity RelationshipsSynthetic Medicinal ChemistryAntiviral PharmacologyEnzyme InhibitionPotency OptimizationStructure-activity Relationship AnalysisAntiviral Structure-activity RelationshipsCrystal Structure Analysis
Several 3-hydroxyquinolin-2(1H)-ones derivatives were synthesized and evaluated as inhibitors of 2009 pandemic H1N1 influenza A endonuclease. All five of the monobrominated 3-hydroxyquinolin(1H)-2-ones derivatives were synthesized. Suzuki-coupling of p-fluorophenylboronic acid with each of these brominated derivatives provided the respective p-fluorophenyl 3-hydroxyquinolin(1H)-2-ones. In addition to 3-hydroxyquinolin-2(1H)-one, its 4-methyl, 4-phenyl, 4-methyl-7-(p-fluorophenyl), and 4-phenyl-7-(p-fluorophenyl) derivatives were also synthesized. Comparative studies on their relative activity revealed that both 6- and 7-(p-fluorophenyl)-3-hydroxyquinolin-2(1H)-one are among the more potent inhibitors of H1N1 influenza A endonuclease. An X-ray crystal structure of 7-(p-fluorophenyl)-3-hydroxyquinolin-2(1H)-one complexed to the influenza endonuclease revealed that this molecule chelates to two metal ions at the active site of the enzyme.
21
The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit
Alexandre Dias, Denis Bouvier, Thibaut Crépin et al. · Nature · 2009 · 748 citations
Crystal structure of an avian influenza polymerase PAN reveals an endonuclease active site
Puwei Yuan, Mark Bartlam, Zhiyong Lou et al. · Nature · 2009 · 488 citations
Crystal structure of the polymerase PAC–PB1N complex from an avian influenza H5N1 virus
Xiaojing He, Jie Zhou, Mark Bartlam et al. · Nature · 2008 · 273 citations